Originally thought to be restricted to the eukaryotic kingdom, reversible protein phosphorylation on serine, threonine and tyrosine residues has emerged as a widespread signaling mechanism in prokaryotes and has turned into a highly active field of research in modern molecular microbiology. Mycobacterium tuberculosis was among the first microorganisms for which genomic data indicated the presence of eukaryotic-like Ser/Thr kinases (STPKs) and has been intensively studied since, given the high interest in STPKs as possible targets for the development of new antituberculosis drugs 1, 2 . PknA is found together with a second kinase, PknB, in a conserved operon that also includes two genes coding for FHA domain proteins . The two kinases, PknA and PknB, are thought to be involved in the control of cell division and were shown to be essential for mycobacterial growth 2 .
Although PknB is one of the most studied eukaryotic-like bacterial kinases and the first for which the crystal structure became available 1 , the detailed signaling pathway(s) in which these STPKs could be involved remain elusive. Moreover, in contrast to PknB, for which structural and biochemical evidence has started to shed light on its regulation mechanisms 3 , the absence of structural data for PknA has hampered further functional studies, despite the likely involvement of this kinase in common signaling pathways. We describe here the crystal structure of the catalytic domain of PknA and the identification of several autophosphorylation sites in the intracellular region, providing first clues about the regulation mechanism of this essential mycobacterial kinase. Cloning, expression and purification. To produce recombinant soluble protein for structural studies, the portion of the pknA gene (rv0015c) coding for the predicted intracellular moiety (PknA ) was amplified by PCR from the cosmid MTCY10H4, introducing a 5' DNA sequence coding for the TEV protease cleavage site (ENLYFQG), as well as a EcoRI restriction site at both ends. The purified PCR fragment was then cloned in the pET-28a vector leading to plasmid pM260, which was subsequently used to transform the E. coli strain BL21(DE3)pLysS for protein production. The transformed strain was grown at 30°C in LB medium supplemented with 50 µg/ml kanamycin and 30 µg/ml chloramphenicol, and protein overexpression was achieved by induction with 1 mM IPTG once OD 600 ~ 0.7, followed by 3.0 h growth at 30°C. Cells were then harvested by centrifugation, washed with PBS (140 mM NaCl, 2.7 mM KCl, 10 mM Na 2 HPO 4 , 1.8 mM KH 2 PO 4 , pH 7.3) and frozen at -80°C. Pellets were thawed, resuspended in lysis buffer (50 mM NaH 2 PO 4 , 500 mM NaCl, 25 mM imidazole, 5% glycerol; pH 8.0) and lysed by sonication on ice;
lysates were then centrifuged at 26,800 x g for 1 h, filtered on a 0.45 µm membrane and loaded with a peristaltic pump onto a 1 ml HisTrap Ni 2+ -IMAC column (GE Healthcare). PknA was eluted applying a 25-400 mM imidazole gradient in the same buffer; the fractions containing the recombinant protein, as confirmed by 12%
SDS-PAGE, were pooled and dialysed overnight at 18°C against a specific PknA buffer (25 mM Hepes-Na pH 8.0, 500 mM NaCl, 5% glycerol, 1 mM DTT). During the dialysis a recombinant His 6 -tagged TEV protease was added to a 1:35 w/w ratio.
The dialyzed sample was passed by gravity flow through 1.0 ml of Ni-NTA resin (Qiagen) in order to eliminate the TEV protease and the cleaved His 6 expression tag, eluted with 3 ml of PknA buffer supplemented with 50 mM imidazole, concentrated and injected onto a HiLoad 16/60 Superdex 75 size exclusion column (GE 21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  P  e  e  r  R  e  v  i  e  w Healthcare), equilibrated in the PknA buffer (with no imidazole) and run at 1 ml/min.
Peak fractions containing PknA 1-336 were pooled and concentrated up to 36 mg/ml with a 10 kDa-cut off Vivaspin concentrator (Sartorius). The concentrated protein, with a purity > 95% as estimated by Coomassie blue staining on SDS-PAGE, was flash-frozen in liquid nitrogen and stored at -80°C.
Phosphorylation site identification by tandem mass spectrometry. Protein samples were digested with different proteolytic enzymes (chymotrypsin, trypsin and endoproteinase GluC) by incubation overnight at 37°C. The resulting peptides were separated using a nano-HPLC system (Proxeon EasynLC, Thermo) fitted with a reverse-phase column (easy C18 column, 3 µm; 75 µm ID×10 cm; Proxeon, Thermo) Crystallization. Initial crystallization screenings of PknA were carried out at 18°C by the sitting drop method in a 96-well format (200+200 nl drops dispensed by a Cartesian nanolitre system). Microcrystals were identified in a crystallization condition containing 4.3 M NaCl, 100 mM Hepes-Na pH 8.0, which was refined in several steps by preparing hand-made hanging drops in 24-well plates at the same temperature. The final crystallization buffer was 3.8 M NaCl, 100 mM MES pH 6.7, 14.3 mM Na acetate pH 4.5, with which crystals suitable to structural determination grew in 8 to 10 days by microseeding from the original condition. Crystals were flashfrozen in liquid nitrogen after quick soaking in a cryoprotectant mixture made of 75% crystallization solution and 25% glycerol.
Data collection, structure determination and refinement. X-ray diffraction data were collected at 100 K on the beamline ID14-2 at the European Synchrotron Radiation 
RESULTS AND DISCUSSION
Overall structure. Although attempts to overexpress the N-terminal catalytic domain (residues 1-276) of PknA in E. coli were unsuccessful, we were able to express and purify the whole intracellular moiety of the kinase, including the entire juxtamembrane segment (residues 277-336), as a His 6 -tagged soluble protein to a satisfactorily yield (~ 3.5 mg/l of culture). This construct is active on the FHA domain substrate GarA, as reported 9 . After proteolytic removal of the affinity tag, the recombinant protein crystallized in high salt conditions (around 4 M NaCl). The crystals belong to the monoclinic space group C2 and the 3D structure has been determined to 2.9 Å using molecular replacement methods ( Table 1 ). The asymmetric unit contains three molecules of PknA, all of which were traceable from the Nterminus (with the exception of Met1 and Ser2, not visible in all chains) to residue Pro289, corresponding to the whole catalytic domain plus the first 13 residues of the juxtamembrane segment. In contrast, no supporting electron density was observed for the remaining part of the juxtamembrane segment (residues Gly290 to Gly336). The catalytic domain shows the canonical, bi-lobal protein kinase fold, with an N-terminal lobe (Met1 to Val98), composed of a five-stranded antiparallel β-sheet plus the functionally important αC helix (Pro52 to Ala66), followed by a mostly α-helical Cterminal lobe (residues Asn98 to Gly277) that includes helices αD to αI (Fig. 1A) .
Just outside the catalytic domain, the N-terminal visible portion of the juxtamembrane segment makes a left-handed PPII helix extension to the C-terminal lobe of the kinase (Fig. 1B) . This segment makes two H-bonds with the catalytic domain, one between Despite our attempts to get co-crystals of PknA with commercially available nonhydrolysable ATP analogs, the catalytic site, situated at the interface between the two lobes as in all Ser/Thr and Tyr protein kinases, shows no bound nucleotide or divalent ion. Nevertheless, the ensemble of well-documented elements of Hanks-type kinases is easily identifiable. The activation loop is comprised of 28 residues between the sequence motifs DFG (Asp159-Phe160-Gly161) and APE (Ala185-Pro186-Glu187), two of the extremely conserved features of protein kinases ( Fig. 1C; Fig. 2A ). Among the other traits of Hanks-type kinases, the conserved lysine on the β3 strand (Lys42), involved in the binding of the ATP α and β phosphates, the equally conserved glutamate on the critical αC helix (Glu61), involved in the correct positioning of the same lysine by a salt bridge, and the so-called HRD motif (His139-Arg140-Asp141) that identifies the catalytic loop and allow to classify PknA as an RD-kinase ( Fig.   2A) . However, the whole activation loop and part of the following P+1 loop are disordered in each of the three chains in the asymmetric unit, as judged by the lack of supporting electron density for residues 168-177 (chain A), 164-174 (chain B), 164-175 (chain C). . However, the fragmentation properties of this multiply phosphorylated peptide preclude the detection of sequence-specific ion signals, thus rendering the localization of phosphorylated sites difficult.
In a previous report, eight phosphorylation sites were identified in PknA 1-338 11 .
Except for Ser212, all the other sites were also detected in our experimental
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